Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Beyrend

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|December 31, 2019
Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and CytosploreGuillaume Beyrend, Koen Stam, Ferry Ossendorp, et al.
F1000Research|October 23, 2018
Cytomegalovirus infection and progressive differentiation of effector-memory T cellsIris N Pardieck, Guillaume Beyrend, Anke Redeker, et al.
Computational and Structural Biotechnology Journal|November 20, 2018
<i>Cytofast</i>: A workflow for visual and quantitative analysis of flow and mass cytometry data to discover immune signatures and correlationsGuillaume Beyrend, Koen Stam, Thomas Höllt, et al.
Clinical Rheumatology|June 12, 2023
Spondyloarthritis mass cytometry immuno-monitoring: a proof of concept study in the tight-control and treat-to target TiCoSpA trialHester Koppejan, Guillaume Beyrend, Marjolijn Hameetman, et al.
Iscience|January 18, 2021
Memory CD8<sup>+</sup> T cell heterogeneity is primarily driven by pathogen-specific cues and additionally shaped by the tissue environmentEsmé T I van der Gracht, Guillaume Beyrend, Tamim Abdelaal, et al.
Journal for Immunotherapy of Cancer|October 1, 2020
Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor modelsMarit van Elsas, Jan Willem Kleinovink, Matthijs Moerland, et al.
Journal for Immunotherapy of Cancer|August 16, 2019
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptorsGuillaume Beyrend, Esmé van der Gracht, Ayse Yilmaz, et al.
Frontiers in Immunology|November 16, 2020
Visualizing Dynamic Changes at the Maternal-Fetal Interface Throughout Human Pregnancy by Mass CytometryAnita van der Zwan, Vincent van Unen, Guillaume Beyrend, et al.
Frontiers in Immunology|July 11, 2022
Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel DiseaseVincent van Unen, Laura F Ouboter, Na Li, et al.
Cell Reports. Medicine|February 16, 2023
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrumTetje C van der Sluis, Guillaume Beyrend, Esmé T I van der Gracht, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|December 31, 2019
Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and CytosploreGuillaume Beyrend, Koen Stam, Ferry Ossendorp, et al.
F1000Research|October 23, 2018
Cytomegalovirus infection and progressive differentiation of effector-memory T cellsIris N Pardieck, Guillaume Beyrend, Anke Redeker, et al.
Computational and Structural Biotechnology Journal|November 20, 2018
<i>Cytofast</i>: A workflow for visual and quantitative analysis of flow and mass cytometry data to discover immune signatures and correlationsGuillaume Beyrend, Koen Stam, Thomas Höllt, et al.
Clinical Rheumatology|June 12, 2023
Spondyloarthritis mass cytometry immuno-monitoring: a proof of concept study in the tight-control and treat-to target TiCoSpA trialHester Koppejan, Guillaume Beyrend, Marjolijn Hameetman, et al.
Iscience|January 18, 2021
Memory CD8<sup>+</sup> T cell heterogeneity is primarily driven by pathogen-specific cues and additionally shaped by the tissue environmentEsmé T I van der Gracht, Guillaume Beyrend, Tamim Abdelaal, et al.
Journal for Immunotherapy of Cancer|October 1, 2020
Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor modelsMarit van Elsas, Jan Willem Kleinovink, Matthijs Moerland, et al.
Journal for Immunotherapy of Cancer|August 16, 2019
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptorsGuillaume Beyrend, Esmé van der Gracht, Ayse Yilmaz, et al.
Frontiers in Immunology|November 16, 2020
Visualizing Dynamic Changes at the Maternal-Fetal Interface Throughout Human Pregnancy by Mass CytometryAnita van der Zwan, Vincent van Unen, Guillaume Beyrend, et al.
Frontiers in Immunology|July 11, 2022
Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel DiseaseVincent van Unen, Laura F Ouboter, Na Li, et al.
Cell Reports. Medicine|February 16, 2023
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrumTetje C van der Sluis, Guillaume Beyrend, Esmé T I van der Gracht, et al.
Pageof 2